Kevin D. Staton

Biodistribution and Dosimetry of ¹⁸F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies

Neeta Pandit‐Taskar, Pat Zanzonico, Kevin D. Staton et al. · Journal of Nuclear Medicine · 2017 · 129 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of ¹⁸F-(2<i>S</i>,4<i>R</i>)-4-Fluoroglutamine

Mark Dunphy, James J. Harding, Sriram Venneti et al. · Radiology · 2018 · 106 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

Diane Reidy‐Lagunes, Neeta Pandit‐Taskar, Joseph A. O’Donoghue et al. · Clinical Cancer Research · 2019 · 105 citations · Full text

Medicine, Oncology, Pharmacology +16

Nanoscale nuclear architecture for cancer diagnosis beyond pathology via spatial-domain low-coherence quantitative phase microscopy

Pin Wang, Rajan K. Bista, Walid E. Khalbuss et al. · Journal of Biomedical Optics · 2010 · 50 citations · Full text

Medicine, Oncology, Pathology +15

Pharmacokinetic Assessment of ¹⁸F-(2<i>S,</i>4<i>R</i>)-4-Fluoroglutamine in Patients with Cancer

Milan Grkovski, Reema Goel, Simone Krebs et al. · Journal of Nuclear Medicine · 2019 · 36 citations · Full text

Medicine, Oncology, Pharmacokinetics +14